Suzetrigine: Understanding Its Mechanism of Action in Pain Relief│ PHARMACOLOGY скачать в хорошем качестве

Suzetrigine: Understanding Its Mechanism of Action in Pain Relief│ PHARMACOLOGY

Updated (31st Jan 2025): On January 30th, 2025 the US Food and Drug Administration (FDA) approved suzetrigine, (JOURNAVX™) for the treatment of adults with moderate-to-severe acute pain ( https://www.fda.gov/news-events/press... ). Suzetrigine is the first new class of acute pain medication approved in over two decades, offering a potential alternative to opioids. Learn how this promising new drug works and its potential impact on the future of pain management. Disclaimer: This YouTube channel is not intended to provide diagnosis, treatment, or medical advice. The content provided in this video is for informational purposes only. This should not be considered as a substitute for healthcare professional advice. Please consult a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options. The statements about specific products are not to diagnose, treat, cure, or prevent disease. References: 1. https://www.nih.gov/news-events/news-... 2. https://www.pharmaceutical-technology... 3. https://www.nature.com/articles/d4157... 4. Bovill JG. Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugs. Eur J Anaesthesiol Suppl. 1997 May;15:9-15. doi: 10.1097/00003643-199705001-00003. PMID: 9202932. 5. Osteen JD, Immani S, Tapley TL, Indersmitten T, Hurst NW, Healey T, Aertgeerts K, Negulescu PA, Lechner SM. Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain. Pain Ther. 2025 Jan 8. doi: 10.1007/s40122-024-00697-0. Epub ahead of print. PMID: 39775738. 6. https://www.drugs.com/medical-answers... #Suzetrigine #PainRelief #PainMedication #FDAApproval #PainManagement #ChronicPain #AcutePain #Healthcare #MedicalScience #NaV18Inhibitor #PainSignalInhibition #Neuroscience #PharmaceuticalNews #MedicalResearch #MedicalEducation #Pharmacology #MedEd #JOURNAVX